Diabetic Nephropathy: References

Content provided by Healthwise

References

Citations

1. American Diabetes Association (2007). Standards of medical care in diabetes. Clinical Practice Recommendations 2007. Diabetes Care, 30(Suppl 1): S4–S41.

2. American Diabetes Association (2004). Nephropathy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S79–S83.

3. Steele AW (2001). Kidney disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 429–465. Hamilton, ON: BC Decker.

4. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2001). Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). Journal of Pediatrics, 139(6): 804–812.

5. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002). Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA, 287(19): 2563–2569.

6. Van Dam RM, et al. (2002). Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Annals of Internal Medicine, 136(3): 201–209.

7. ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001). Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Annals of Internal Medicine, 134(5): 370–379.

8. Gerstein HC, et al. (2000). Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet, 355(9200): 253–259.

9. American Diabetes Association (2004). Preconception care of women with diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S76–S78.

Other Works Consulted

• American Diabetes Association (2005). Diabetes complications and prevention. In American Diabetes Association Complete Guide to Diabetes, 4th ed. pp. 320–324. Alexandria, VA: American Diabetes Association.

• Bakris GL (2003). The evolution of treatment guidelines for diabetic nephropathy. Postgraduate Medicine, 113(5): 35–50.

E-mail This | Print This Previous Chapter | Next Chapter

Last updated:	January 17, 2007
Author:	Robin Parks, MS
Reviewed By:	Kathleen Romito, MD - Family Medicine, D.C. Mendelssohn, MD, FRCPC - Nephrology
Editors:	Kathleen M. Ariss, MS, Pat Truman